.
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
may 17, 2018
.
over the years, i�ve talked to reporters who are solidly addicted to obfuscations. like any addict, they have an army of excuses to rationalize their behavior.
.
follow daily mail